LSTA

LISATA THERAPEUTICS, INC.

Healthcare · Biotechnology

$144.81 sample

+2.59 (+1.82%) 1D

Market cap

$204.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-13

Alerts

8

Price$144.81 +19.52% 3M daily closessample

145.08120.72

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13SECForm 144 filed
Oct 02INSInsider buy: 10% owner
Sep 29INSInsider sell: Chief Financial Officer
Sep 21INSInsider sell: EVP, Operations
Sep 16INSInsider buy: General Counsel
Sep 08INSInsider sell: Chief Financial Officer
Sep 01INSInsider sell: General Counsel
Aug 25INSInsider sell: General Counsel

Sign up to see the real LSTA record →

Company facts

SEC EDGAR registration

Name: LISATA THERAPEUTICS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -30sample, -100 to +100
Reporting currency: USD

Who is positioning in LSTA

sample

Insiders: 21 insider transactions over 90 days, net selling, $7.0M
Congress: 2 members traded over 90 days
Institutions · 13F: 6 funds hold $2.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.6B +18.6% y/y

Q4 2024Q3 2026

Inventory$4.4B +14.3% y/y

Q4 2024Q3 2026

Accounts receivable$3.3B +11.2% y/y

Q4 2024Q3 2026

Total debt$9.1B +19.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $122.4B -12.2% 3M
Sample peer B: $31.4B +14.0% 3M
Sample peer C: $193.1B +0.1% 3M
Sample peer D: $38.1B -9.1% 3M
Sample peer E: $193.2B -4.7% 3M